Dr. Bruce D. Gelb
A pioneering pediatric cardiologist and geneticist from the Icahn School of Medicine at Mount Sinai, is known for his transformative research uncovering the genetic causes of congenital heart disease (CHD) and related disorders. His early work, supported by the National Institutes of Health, helped establish the molecular foundations of CHD and led to landmark discoveries explaining why some children are born with heart defects. Among his most influential contributions was identifying the first genetic cause of Noonan syndrome, work that paved the way for understanding a broader group of developmental conditions now known as the RASopathies. These insights have shaped how physicians worldwide diagnose, predict, and treat these disorders. “Dr. Gelb exemplifies the spirit of the John Howland Award through his groundbreaking research, visionary leadership, and unwavering dedication to mentoring future leaders in pediatrics,” said Stephen R. Daniels, MD, PhD, President of the American Pediatric Society. “His work has profoundly shaped our understanding of congenital heart disease and developmental disorders, and his influence continues to elevate the field of pediatric medicine. In addition, during his presidency of APS, he led a strategic plan process that transformed our organization into one of action, leveraging the expertise of our members to improve the health and well-being of children and adolescents.” Beyond his scientific achievements, Dr. Gelb has been an exceptional leader and mentor. As the founding Director of the Mindich Child Health and Development Institute and Dean for Child Health Research at the Icahn School of Medicine at Mount Sinai, he has built a thriving research community dedicated to improving child health through innovation and collaboration. Under his leadership, the institute has expanded major initiatives in clinical research, health services, and artificial intelligence. Dr. Gelb has combined visionary science with a steadfast commitment to mentoring the next generation of physician-scientists, leaving an enduring legacy in pediatric medicine and molecular genetics. Throughout his career, Dr. Gelb has been a dedicated leader in national academic medical organizations, with a particular focus on advancing pediatric research and advocacy. He served on the APS Council from 2012 to 2020, including a term as President. Dr. Gelb also played a pivotal role in the Pediatric Academic Societies (PAS) meetings, serving as Program Chair in 2010 and 2011. He later became the inaugural President of the newly formed PAS Board, where he was instrumental in establishing the organization’s bylaws and governance structure. Most recently, Dr. Gelb completed his term as President of the American Society of Human Genetics. APS looks forward to celebrating Dr. Gelb and honoring a legacy that will inspire the next generation of pediatric leaders.
A pioneering pediatric cardiologist and geneticist from the Icahn School of Medicine at Mount Sinai, is known for his transformative research uncovering the genetic causes of congenital heart disease (CHD) and related disorders. His early work, supported by the National Institutes of Health, helped establish the molecular foundations of CHD and led to landmark discoveries explaining why some children are born with heart defects. Among his most influential contributions was identifying the first genetic cause of Noonan syndrome, work that paved the way for understanding a broader group of developmental conditions now known as the RASopathies. These insights have shaped how physicians worldwide diagnose, predict, and treat these disorders. “Dr. Gelb exemplifies the spirit of the John Howland Award through his groundbreaking research, visionary leadership, and unwavering dedication to mentoring future leaders in pediatrics,” said Stephen R. Daniels, MD, PhD, President of the American Pediatric Society. “His work has profoundly shaped our understanding of congenital heart disease and developmental disorders, and his influence continues to elevate the field of pediatric medicine. In addition, during his presidency of APS, he led a strategic plan process that transformed our organization into one of action, leveraging the expertise of our members to improve the health and well-being of children and adolescents.” Beyond his scientific achievements, Dr. Gelb has been an exceptional leader and mentor. As the founding Director of the Mindich Child Health and Development Institute and Dean for Child Health Research at the Icahn School of Medicine at Mount Sinai, he has built a thriving research community dedicated to improving child health through innovation and collaboration. Under his leadership, the institute has expanded major initiatives in clinical research, health services, and artificial intelligence. Dr. Gelb has combined visionary science with a steadfast commitment to mentoring the next generation of physician-scientists, leaving an enduring legacy in pediatric medicine and molecular genetics. Throughout his career, Dr. Gelb has been a dedicated leader in national academic medical organizations, with a particular focus on advancing pediatric research and advocacy. He served on the APS Council from 2012 to 2020, including a term as President. Dr. Gelb also played a pivotal role in the Pediatric Academic Societies (PAS) meetings, serving as Program Chair in 2010 and 2011. He later became the inaugural President of the newly formed PAS Board, where he was instrumental in establishing the organization’s bylaws and governance structure. Most recently, Dr. Gelb completed his term as President of the American Society of Human Genetics. APS looks forward to celebrating Dr. Gelb and honoring a legacy that will inspire the next generation of pediatric leaders.
